As of Feb 17
| +0.29 / +0.47%|
The 19 analysts offering 12-month price forecasts for AbbVie have a median target of 71.12, with a high estimate of 90.00 and a low estimate of 55.00. The median estimate represents a +15.14% increase from the last price of 61.77.
The current consensus among 22 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.